Unknown

Dataset Information

0

Paracentric Inversion of Chromosome 21 Leading to Disruption of the HLCS Gene in a Family with Holocarboxylase Synthetase Deficiency.


ABSTRACT: Holocarboxylase synthetase (HLCS) deficiency is a rare autosomal recessive disorder that presents with multiple life-threatening metabolic derangements including metabolic acidosis, ketosis, and hyperammonemia. A majority of HLCS deficiency patients respond to biotin therapy; however, some patients show only a partial or no response to biotin therapy. Here, we report a neonatal presentation of HLCS deficiency with partial response to biotin therapy. Sequencing of HLCS showed a novel heterozygous mutation in exon 5, c.996G>C (p.Gln332His), which likely abolishes the normal intron 6 splice donor site. Cytogenetic analysis revealed that the defect of the other allele is a paracentric inversion on chromosome 21 that disrupts HLCS. This case illustrates that in addition to facilitating necessary family testing, a molecular diagnosis can optimize management by providing a better explanation of the enzyme's underlying defect. It also emphasizes the potential benefit of a karyotype in cases in which molecular genetic testing fails to provide an explanation.

SUBMITTER: Quinonez SC 

PROVIDER: S-EPMC5509548 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

Paracentric Inversion of Chromosome 21 Leading to Disruption of the HLCS Gene in a Family with Holocarboxylase Synthetase Deficiency.

Quinonez Shane C SC   Seeley Andrea H AH   Lam Cindy C   Glover Thomas W TW   Barshop Bruce A BA   Keegan Catherine E CE  

JIMD reports 20160813


Holocarboxylase synthetase (HLCS) deficiency is a rare autosomal recessive disorder that presents with multiple life-threatening metabolic derangements including metabolic acidosis, ketosis, and hyperammonemia. A majority of HLCS deficiency patients respond to biotin therapy; however, some patients show only a partial or no response to biotin therapy. Here, we report a neonatal presentation of HLCS deficiency with partial response to biotin therapy. Sequencing of HLCS showed a novel heterozygous  ...[more]

Similar Datasets

| S-EPMC4236861 | biostudies-literature
| S-EPMC2630166 | biostudies-literature
| S-EPMC4375121 | biostudies-literature
| S-EPMC9997024 | biostudies-literature
| S-EPMC2662232 | biostudies-literature
| S-EPMC1858705 | biostudies-literature
| S-EPMC9563324 | biostudies-literature
| S-EPMC1712444 | biostudies-other
| S-EPMC9775520 | biostudies-literature
| S-EPMC4906125 | biostudies-literature